EMMA
PINK Emmaus Life Sciences, Inc.$0.0584 ↑ +0.0000 (+0.00%) Trading Up from the previous close of $0.0584, $0.0065 below the day’s high of $0.0649
- YTD change
- +349.23%
- vs 20-day SMA
- -2.93%
- vs 200-day SMA
- +212.60%
Price ranges
Price & Performance
+0.05 (+478.22%) / 6M
Signals & Sentiment
Momentum, market sentiment, and recent alerts
- The stock is 33.6% away from all-time highs of $0.0879
- EMMA is up 349% since the beginning of the year
- EMMA is up 387% over the past 12 months
- EMMA is down 5% over the past 1 month
- 0% of all EMMA investors are betting against EMMA
EMMA reads n/a: price sits above one of the two key moving averages, the 12-month move is +390.8%.
- Previous minute
- +$0.0000
- Last hour
- +$0.0163
- Last 5 days
- +38.39%
- vs 8-day SMA
- +2.82%
Financial Strength
Earnings, valuation, and balance sheet
Earnings
Valuation
Balance sheet & scale
Company & Peers
Company profile and competitor comparison
Company profile
Emmaus Life Sciences, Inc. engages in the discovery, development, marketing, and sale of treatments and therapies for rare and orphan diseases. It operates through the Marketing and Sales of Endari segment. The company was founded on March 20, 1987 and is headquartered in Torrance, CA.
You looked up one stock
Trade Ideas watches them all
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.